Search

everythinglearnresearchcommunity

for

Search:↓

Buserelin safely and effectively suppresses early puberty, potentially improving final height.

Flutamide rarely causes liver toxicity in prostate cancer patients.

New hormonal therapies can help treat advanced prostate cancer but may cause testicular issues.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Hair loss is a common side effect of hormone treatments for cancer.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

The nafarelin test can reliably distinguish between gonadotropin deficiency and delayed puberty in teenage boys.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

GnRH treatment can reduce breast cancer cell invasion.

Continuous glucose monitoring and GLP-1 receptor agonists improve diabetes management, but personalized care and education are crucial.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Tamoxifen effectively treats gynecomastia without causing impotence.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

There is no significant link between insulin resistance and certain hair disorders like idiopathic hirsutism and androgenic alopecia.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Certain hormone treatments can improve acne and related conditions in women.